Royal Bank of Canada’s EnteroMedics Inc. ETRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1
Closed 7438
2017
Q3
$0 Sell
1
-13
-93% -$38 ﹤0.01% 7426
2017
Q2
$0 Sell
14
-2
-13% -$10 ﹤0.01% 7182
2017
Q1
$0 Buy
16
+14
+700% +$104 ﹤0.01% 7123
2016
Q4
$0 Sell
2
-1
-33% -$5 ﹤0.01% 7065
2016
Q3
$0 Hold
3
﹤0.01% 6932
2016
Q2
$0 Buy
+3
New +$137 ﹤0.01% 6878
2016
Q1
Hold
0
7161
2015
Q4
Sell
-1
Closed 7300
2015
Q3
$0 Hold
1
﹤0.01% 7114
2015
Q2
$1K Buy
+1
New +$1.15K ﹤0.01% 6554
2014
Q1
Sell
-1
Closed -$2K 6527
2013
Q4
$2K Hold
1
﹤0.01% 5805
2013
Q3
$1K Sell
1
-1
-50% -$1.16K ﹤0.01% 6054
2013
Q2
$2K Buy
+2
New +$2.11K ﹤0.01% 5684

Other funds holding ETRM

Royal Bank of Canada's ETRM Position: Q4 2017 in Review

Royal Bank of Canada sold out of EnteroMedics Inc. (ETRM) in Q4 2017, closing a stake of 1 share.

Royal Bank of Canada first reported a position in ETRM in Q2 2013 and held it in 11 quarters. The position peaked at $2K in Q4 2013. 1 fund tracked by Wall St. Rank holds ETRM as of Q4 2017.

  • Royal Bank of Canada reported no remaining EnteroMedics Inc. position as of Q4 2017 after selling out during the quarter.
  • Royal Bank of Canada sold 1 EnteroMedics Inc. share in Q4 2017.
  • Royal Bank of Canada first reported a position in EnteroMedics Inc. in Q2 2013 and held it in 11 quarters.
  • Royal Bank of Canada's EnteroMedics Inc. position peaked at $2K in Q4 2013.
  • 1 fund tracked by Wall St. Rank held EnteroMedics Inc. as of Q4 2017.

Based on Royal Bank of Canada's 13F filing for Q4 2017, filed 14 Feb 2018.